Houjou T - Search Results

1

[The elevation of serum iron level with oral administration of medroxyprogesterone acetate (MPA) in patients with breast cancer].

Kadota K, Wada T, Watatani M, Houjou T, Mori N, Yasutomi M. Kadota K, et al. Among authors: houjou t. Gan To Kagaku Ryoho. 1991 May;18(6):983-7. Gan To Kagaku Ryoho. 1991. PMID: 1827574 Japanese.

2

[Clinical evaluation of estramustine phosphate in the treatment of patients with advanced breast cancers].

Wada T, Morikawa E, Houjou T, Kadota K, Mori N, Matsunami N, Watatani M, Yasutomi M. Wada T, et al. Among authors: houjou t. Gan To Kagaku Ryoho. 1990 Sep;17(9):1901-4. Gan To Kagaku Ryoho. 1990. PMID: 2393306 Japanese.

3

[Combination therapy with medroxyprogesterone acetate and tegafur in tamoxifen- and adriamycin-resistant advanced breast cancers].

Wada T, Matunami N, Houjou T, Morikawa E, Mori N, Nakano K, Aizawa M, Kurooka K, Kadota K, Yamato M, et al. Wada T, et al. Among authors: houjou t. Gan To Kagaku Ryoho. 1989 May;16(5):2087-92. Gan To Kagaku Ryoho. 1989. PMID: 2525004 Japanese.

4

A combined chemo-endocrine treatment with tegafur, adriamycin, methotrexate and tamoxifen for advanced renal cell carcinoma.

Wada T, Houjou T, Kubo R, Yasutomi M, Kurita T. Wada T, et al. Among authors: houjou t. Anticancer Res. 1993 Nov-Dec;13(6B):2465-7. Anticancer Res. 1993. PMID: 8135483

5

Antitumor and endocrine effects of an aromatase inhibitor (CGS 16949A) on DMBA-induced rat mammary tumor.

Houjou T, Wada T, Yasutomi M. Houjou T, et al. Clin Ther. 1993 Jan-Feb;15(1):137-47. Clin Ther. 1993. PMID: 8458043

6

Conventional Dose CAF Therapy versus Low Dose Adriamycin Therapy in the Treatment of Advanced Breast Cancer.

Wada T, Yamauchi E, Nishiyama K, Nakatani Y, Houjou T, Watatani M, Koyama H, Yasutomi M. Wada T, et al. Among authors: houjou t. Breast Cancer. 1994 Jul 30;1(1):51-56. doi: 10.1007/BF02967375. Breast Cancer. 1994. PMID: 11091507

7

CAF versus CAF plus Medroxyprogesterone Acetate for Treatment of Liver Metastases of Breast Cancer.

Wada T, Nishiyama K, Nakatani Y, Houjou T, Inui H, Yamauchi E, Hara S, Yasutomi M. Wada T, et al. Among authors: houjou t. Breast Cancer. 1995 Apr 30;2(1):65-70. doi: 10.1007/BF02966898. Breast Cancer. 1995. PMID: 11091534

8

PI3K/Akt/mTOR signalling pathway activation in patients with ER-positive, metachronous, contralateral breast cancer treated with hormone therapy.

Kanaizumi H, Higashi C, Tanaka Y, Hamada M, Shinzaki W, Azumi T, Hashimoto Y, Inui H, Houjou T, Komoike Y. Kanaizumi H, et al. Among authors: houjou t. Oncol Lett. 2019 Feb;17(2):1962-1968. doi: 10.3892/ol.2018.9759. Epub 2018 Nov 26. Oncol Lett. 2019. PMID: 30675261 Free PMC article.

9

Oral sustained-release cisplatin capsule.

Houjou T, Nakano K, Ike O, Wada H, Hitomi S, Shinmi Y, Danno N, Yoshikawa Y, Takada K. Houjou T, et al. J Pharm Pharmacol. 1996 May;48(5):474-8. doi: 10.1111/j.2042-7158.1996.tb05957.x. J Pharm Pharmacol. 1996. PMID: 8799870

10

Biodistribution of cyclosporin encapsulated in liposomes modified with bioadhesive polymer.

Yoshikawa Y, Miyazaki M, Houjou T, Komuta Y, Yoshikawa H, Takada K. Yoshikawa Y, et al. Among authors: houjou t. J Pharm Pharmacol. 1997 Jul;49(7):661-8. doi: 10.1111/j.2042-7158.1997.tb06089.x. J Pharm Pharmacol. 1997. PMID: 9255708

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20 results

Search Page

Filters